Yet another series of tests supporting the use of omega 3 fatty acids to treat high triglyceride levels has proven out. Amarin Corp has been issued approval for an FDA review for a new drug based on fish oil that will be used to treat individuals with high triglyceride levels. While this is not the first drug that is omega 3 based, it is another example of the ongoing recognition of fish oil (omega 3s) as a significant fatty acid to include in one’s diet.
For more information, please feel free to read the PharmaTimes article at PharmaTimes.
